VCM
AKTS icon

Versant Capital Management’s Aktis Oncology AKTS Stock Holding History

Versant Capital Management’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.31K Buy
+324
New +$7.89K ﹤0.01% 2405

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Versant Capital Management's AKTS Position: Q3 2026 in Review

Versant Capital Management opened a new position in Aktis Oncology (AKTS) in Q3 2026: 324 shares worth $6.31K. The stake represents ﹤0.01% of the portfolio and ranks #2405 among its holdings.

6 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Versant Capital Management held 324 shares of Aktis Oncology worth $6.31K as of Q3 2026.
  • Aktis Oncology was a new Versant Capital Management position in Q3 2026.
  • Aktis Oncology made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2405 holding.
  • 6 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.